UVEAL MELANOMA
Clinical trials for UVEAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new UVEAL MELANOMA trials appear
Sign up with your email to follow new studies for UVEAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Groundbreaking vaccine aims to stop rare eye cancer from returning
⭐️ VACCINE ⭐️ CompletedThis study tested a personalized vaccine made from a patient's own immune cells and tumor RNA to prevent eye cancer (uveal melanoma) from coming back. It included 200 people whose eye tumor was removed and had a high-risk genetic marker (monosomy 3). Participants received the vac…
Matched conditions: UVEAL MELANOMA
Phase: PHASE3 • Sponsor: University Hospital Erlangen • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 17, 2026 02:42 UTC
-
New hope for rare eye cancer: experimental drug extends survival?
Disease control CompletedThis study tested a new drug, IMCgp100, in 378 adults with a specific type of advanced eye cancer (uveal melanoma) that had spread. Participants had not received prior treatment for advanced disease. The goal was to see if IMCgp100 helped them live longer compared to standard tre…
Matched conditions: UVEAL MELANOMA
Phase: PHASE2 • Sponsor: Immunocore Ltd • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Can a cancer pill stall eye tumor spread? new study reveals results
Disease control CompletedThis study tested the drug sorafenib (Nexavar) in 32 adults with uveal melanoma that had spread to other parts of the body. The goal was to see if the drug could stop tumors from growing for at least 24 weeks. Researchers also monitored side effects to understand the drug's safet…
Matched conditions: UVEAL MELANOMA
Phase: PHASE2 • Sponsor: University Hospital, Caen • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
New immune cell therapy shows promise for Hard-to-Treat melanoma
Disease control CompletedThis early-phase study tested a new treatment called TBio-4101 for people with advanced melanoma that did not respond to standard therapies. The treatment uses a patient's own immune cells (TILs) that are selected and grown in the lab, then given back after chemotherapy to help f…
Matched conditions: UVEAL MELANOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 01, 2026 17:54 UTC
-
Early support eases emotional burden in advanced eye cancer
Symptom relief CompletedThis study looked at whether adding supportive care early on helps with the emotional and practical needs of people with metastatic uveal melanoma, a rare eye cancer that has spread. 162 adults took part, some getting standard cancer care alone and others getting early supportive…
Matched conditions: UVEAL MELANOMA
Phase: NA • Sponsor: Institut Curie • Aim: Symptom relief
Last updated Jun 17, 2026 02:42 UTC
-
Blood test may predict success of liver surgery for rare eye cancer
Knowledge-focused CompletedThis study looked at whether measuring tumor DNA in the blood can help track uveal melanoma that has spread to the liver. Researchers took blood samples from 60 patients before and after surgery to remove liver tumors. The goal was to see if changes in tumor DNA levels could show…
Matched conditions: UVEAL MELANOMA
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC